Literature DB >> 15500994

Use of folic acid supplementation and risk for dizygotic twinning.

Bengt Källén1.   

Abstract

BACKGROUND: An increase in dizygotic twinning rate after folic acid supplementation has previously been described, but in a recent study from China, no such effect was seen. AIMS: To further investigate the association between use of folic acid supplement and dizygotic twinning. STUDY
DESIGN: Using the Swedish Medical Birth Registry, the rate of dizygotic twinning among infants of women who reported the use of folic acid was studied, taking a number of confounders into consideration. Comparisons were made with all women recorded in the register. OUTCOME MEASURE: Unlike-sexed twin pairs were used as representatives of dizygotic twinning.
RESULTS: A number of confounders for the association between folic acid use and twinning were identified and taken into consideration. Women who were immigrants (who used less folic acid and had slightly lower twinning rates than women born in Sweden) and women who reported subfertility problems or treatment for subfertility (who had a high use of folic acid and a high twinning rate) were excluded, and adjustment was then made for year of birth, maternal age, parity, and smoking in early pregnancy. Folic acid use and twinning risk increased with maternal age and decreased with parity. Smokers used less folic acid than nonsmokers. Concomitant use of other drugs was no important confounder except for those used at subfertility. The odds ratio (OR) for dizygotic twinning after folic acid supplementation was then 1.71 (95%CI=1.21-2.42) and for the years 2000-2001 even 2.09 (95%CI=1.39-3.12).
CONCLUSION: There is an increase in twinning rate after folic acid supplementation in a Western population which should be taken into consideration when folic acid supplementation or food fortification is recommended.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15500994     DOI: 10.1016/j.earlhumdev.2004.06.002

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  7 in total

1.  Impact of misclassification of in vitro fertilisation in studies of folic acid and twinning: modelling using population based Swedish vital records.

Authors:  R J Berry; R Kihlberg; O Devine
Journal:  BMJ       Date:  2005-02-18

2.  Childhood cancer among twins and higher order multiples.

Authors:  Susan E Puumala; Susan E Carozza; Eric J Chow; Erin E Fox; Scott Horel; Kimberly J Johnson; Colleen McLaughlin; Beth A Mueller; Peggy Reynolds; Julie Von Behren; Logan G Spector
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

3.  Orange juice is a good folate source in respect to folate content and stability during storage and simulated digestion.

Authors:  Veronica Ohrvik; Cornelia Witthöft
Journal:  Eur J Nutr       Date:  2008-03-04       Impact factor: 5.614

Review 4.  Contemporary issues surrounding folic Acid fortification initiatives.

Authors:  Jeong-Hwa Choi; Zoe Yates; Martin Veysey; Young-Ran Heo; Mark Lucock
Journal:  Prev Nutr Food Sci       Date:  2014-12-31

Review 5.  Folic acid supplementation in pregnancy and implications in health and disease.

Authors:  Subit Barua; Salomon Kuizon; Mohammed A Junaid
Journal:  J Biomed Sci       Date:  2014-08-19       Impact factor: 8.410

6.  Prevention of congenital malformations and other adverse pregnancy outcomes with 4.0 mg of folic acid: community-based randomized clinical trial in Italy and the Netherlands.

Authors:  Renata Bortolus; Fenneke Blom; Francesca Filippini; Mireille N M van Poppel; Emanuele Leoncini; Denhard J de Smit; Pier Paolo Benetollo; Martina C Cornel; Hermien E K de Walle; Pierpaolo Mastroiacovo
Journal:  BMC Pregnancy Childbirth       Date:  2014-05-13       Impact factor: 3.007

7.  Antenatal nutritional supplementation and autism spectrum disorders in the Stockholm youth cohort: population based cohort study.

Authors:  Elizabeth A DeVilbiss; Cecilia Magnusson; Renee M Gardner; Dheeraj Rai; Craig J Newschaffer; Kristen Lyall; Christina Dalman; Brian K Lee
Journal:  BMJ       Date:  2017-10-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.